17 results
424B3
BIAF
BioAffinity Technologies Inc
16 Apr 24
Prospectus supplement
7:19pm
, the proportion of cells with high TCPP fluorescence intensity in a patient’s sputum sample is a significant predictor of lung cancer. We hold multiple patents … used in the analysis produced results that included (1) the proportion of cells with a high ratio of high TCPP fluorescence intensity over cell size
POS AM
BIAF
BioAffinity Technologies Inc
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
in CyPath® Lung, the proportion of cells with high TCPP fluorescence intensity in a patient’s sputum sample is a significant predictor of lung cancer. We … intensity over cell size; (2) the proportion of cells with an intermediate ratio of fluorescence intensity caused by the viability dye (FVS510) over
DRS
gxn67jur6dm6q6n
14 Aug 23
Draft registration statement
12:00am
10-K
y1tf5ha19ua 6o00o
31 Mar 23
Annual report
3:40pm
10-Q
jbi 6a2ycm6hpnw
14 Nov 22
Quarterly report
5:11pm
424B4
2ha46sgp4ka4l4hrw4i
2 Sep 22
Prospectus supplement with pricing info
3:25pm
S-1
y8m5gba513u1 w5ku
25 Apr 22
IPO registration
6:16am
- Prev
- 1
- Next